332 related articles for article (PubMed ID: 38675959)
21. Natural history of hepatitis B virus infection: an update for clinicians.
Pungpapong S; Kim WR; Poterucha JJ
Mayo Clin Proc; 2007 Aug; 82(8):967-75. PubMed ID: 17673066
[TBL] [Abstract][Full Text] [Related]
22. Systematic review: chronic viral hepatitis and metabolic derangement.
Wang CC; Cheng PN; Kao JH
Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
[TBL] [Abstract][Full Text] [Related]
23. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China.
Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M
BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750
[TBL] [Abstract][Full Text] [Related]
24. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
Ive P; MacLeod W; Mkumla N; Orrell C; Jentsch U; Wallis CL; Stevens W; Wood R; Sanne I; Bhattacharya D
PLoS One; 2013; 8(12):e74900. PubMed ID: 24324573
[TBL] [Abstract][Full Text] [Related]
25. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.
Liu CJ; Kao JH
Semin Liver Dis; 2013 May; 33(2):97-102. PubMed ID: 23749665
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of viral hepatitis and hepatocellular carcinoma.
El-Serag HB
Gastroenterology; 2012 May; 142(6):1264-1273.e1. PubMed ID: 22537432
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
29. [Natural history and clinical manifestations of chronic hepatitis B virus].
Carneiro de Moura M; Marinho R
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():11-8. PubMed ID: 19100227
[TBL] [Abstract][Full Text] [Related]
30. Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.
Seo Y; Yano Y
World J Gastroenterol; 2014 Oct; 20(37):13284-92. PubMed ID: 25309065
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
32. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
33. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
Lin CL; Kao JH
Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
[TBL] [Abstract][Full Text] [Related]
34. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
35. Effects of antiviral therapy in patients with chronic hepatitis B and cirrhosis.
Okada M; Enomoto M; Kawada N; Nguyen MH
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1095-1104. PubMed ID: 28752768
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus epidemiology.
MacLachlan JH; Cowie BC
Cold Spring Harb Perspect Med; 2015 May; 5(5):a021410. PubMed ID: 25934461
[TBL] [Abstract][Full Text] [Related]
37. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain.
Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
Aliment Pharmacol Ther; 2023 Mar; 57(5):540-548. PubMed ID: 36320189
[TBL] [Abstract][Full Text] [Related]
38. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
[TBL] [Abstract][Full Text] [Related]
39. Global burden of hepatitis B virus: current status, missed opportunities and a call for action.
Hsu YC; Huang DQ; Nguyen MH
Nat Rev Gastroenterol Hepatol; 2023 Aug; 20(8):524-537. PubMed ID: 37024566
[TBL] [Abstract][Full Text] [Related]
40. Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.
Qiu LP; Chen L; Chen KP
Fundam Clin Pharmacol; 2014 Aug; 28(4):364-81. PubMed ID: 24118072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
